Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb 22;21(4):1505.
doi: 10.3390/ijms21041505.

Lipids and Alzheimer's Disease

Affiliations
Review

Lipids and Alzheimer's Disease

Yu-Chia Kao et al. Int J Mol Sci. .

Abstract

Lipids, as the basic component of cell membranes, play an important role in human health as well as brain function. The brain is highly enriched in lipids, and disruption of lipid homeostasis is related to neurologic disorders as well as neurodegenerative diseases such as Alzheimer's disease (AD). Aging is associated with changes in lipid composition. Alterations of fatty acids at the level of lipid rafts and cerebral lipid peroxidation were found in the early stage of AD. Genetic and environmental factors such as apolipoprotein and lipid transporter carrying status and dietary lipid content are associated with AD. Insight into the connection between lipids and AD is crucial to unraveling the metabolic aspects of this puzzling disease. Recent advances in lipid analytical methodology have led us to gain an in-depth understanding on lipids. As a result, lipidomics have becoming a hot topic of investigation in AD, in order to find biomarkers for disease prediction, diagnosis, and prevention, with the ultimate goal of discovering novel therapeutics.

Keywords: Alzheimer disease; cholesterols; fats; fatty acids; lipidomics; lipids.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Roles of lipids in AD pathogenesis.

References

    1. Prince M., Wimo A., Guerchet M., Ali G.-C., Wu Y.-T., Prina M. World Alzheimer Report 2015. The Global Impact of Dementia. An Analysis of Prevalence, Incidence, Cost and Trends. Alzheimer’s Disease International (ADI); London, UK: 2015.
    1. Sastry P.S. Lipids of nervous tissue: Composition and metabolism. Prog. Lipid Res. 1985;24:69–176. doi: 10.1016/0163-7827(85)90011-6. - DOI - PubMed
    1. Giri M., Zhang M., Lu Y. Genes associated with Alzheimer’s disease: An overview and current status. Clin. Interv. Aging. 2016;11:665–681. doi: 10.2147/CIA.S105769. - DOI - PMC - PubMed
    1. Touboul D., Gaudin M. Lipidomics of Alzheimer’s disease. Bioanalysis. 2014;6:541–561. doi: 10.4155/bio.13.346. - DOI - PubMed
    1. Ellis S.R., Paine M.R.L., Eijkel G.B., Pauling J.K., Husen P., Jervelund M.W., Hermansson M., Ejsing C.S., Heeren R.M.A. Automated, parallel mass spectrometry imaging and structural identification of lipids. Nat. Methods. 2018;15:515–518. doi: 10.1038/s41592-018-0010-6. - DOI - PubMed